Winton Group’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-60,606
Closed -$8.1M 1236
2018
Q4
$8.1M Buy
+60,606
New +$9.94M 0.17% 231
2017
Q3
Sell
-4,326
Closed -$1.05M 698
2017
Q2
$1.05M Buy
+4,326
New +$1.02M 0.03% 342
2015
Q2
Sell
-4,063
Closed -$1.21M 411
2015
Q1
$1.21M Sell
4,063
-4,283
-51% -$1.22M 0.01% 387
2014
Q4
$2.15M Sell
8,346
-52,433
-86% -$13.1M 0.03% 377
2014
Q3
$14.7M Sell
60,779
-70,796
-54% -$15.8M 0.1% 299
2014
Q2
$29.3M Buy
+131,575
New +$27.2M 0.2% 214

Other funds holding AGN

Winton Group's AGN Position: Q1 2019 in Review

Winton Group sold out of Allergan plc (AGN) in Q1 2019, closing a stake of 60,606 shares — an estimated $8.1M sold.

Winton Group first reported a position in AGN in Q2 2014 and held it in 6 quarters. The position peaked at $29.3M in Q2 2014. 991 funds tracked by Wall St. Rank hold AGN as of Q1 2019.

  • Winton Group reported no remaining Allergan plc position as of Q1 2019 after selling out during the quarter.
  • Winton Group sold 60,606 Allergan plc shares in Q1 2019, an estimated $8.1M.
  • Winton Group first reported a position in Allergan plc in Q2 2014 and held it in 6 quarters.
  • Winton Group's Allergan plc position peaked at $29.3M in Q2 2014.
  • 991 funds tracked by Wall St. Rank held Allergan plc as of Q1 2019.

Based on Winton Group's 13F filing for Q1 2019, filed 13 May 2019.